[Results of the treatment of adult acute lymphoblastic leukemia according to ALL-2005 protocol as a basis for new trials].
Е. Н. Паровичникова(National Research Center for Hematology Russian Academy of Medical Sciences), Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Л В Гаврилова(National Research Mordovia State University), С. М. Куликов(Ministry of Health of the Russian Federation), Т. П. Загоскина(Kirov Research Institute of Hematology and Blood Transfusion FMBA), А Н Соколов(Ministry of Health of the Russian Federation), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), К Д Капланов, E I Sviridova, Е Н Устинова, В Г Исаев, Е О Грибанова, Е С Маврина
PubMed
January 1, 2009
Cited by 1
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59